Ansell doubles production as extraordinary demand to stay
Key Points
- Revenue ($USm) 937.8, up 25pc from year-earlier 765.5
- Pre-tax profit ($USm) 137.4 v 83.9
- Net profit ($USm) 106.5 v 65.8
- Interim dividend (US¢) 33.2 v 21.8, payable on March 10
Medical glove and protective suit maker Ansell says demand will remain high for its products even when the pandemic is under control because of the steady need for better hygiene practices and the potential demand for annual COVID-19 vaccinations to combat a mutating virus.
Chief executive Magnus Nicolin said the company will bring on eight new production lines in the June half to keep up with the extraordinary demand, after an initial five extra lines were set up in the six months ended December 31.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Manufacturing
Fetching latest articles